Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes

Vinik, 1984, Endocrine tumors of the gastroenteropancreatic axis, 305 Vinik, 1982, Gastrointestinal hormones in clinical medicine, volume 4, 93 Glowniak, 1982, Percutaneous transhepatic venous sampling of gastrin, N Engl J Med, 307, 293, 10.1056/NEJM198207293070507 McCarthy, 1980, The place of surgery in the Zollinger-Ellison syndrome, N Engl J Med, 24, 1344, 10.1056/NEJM198006123022404 Jensen, 1983, Zollinger-Ellison syndrome, 98, 59 Malagelada, 1983, Medical and surgical options in the management of patients with gastrinoma, Gastroenterology, 84, 1524, 10.1016/0016-5085(83)90375-X Passaro, 1983, Of gastrinomas and their management, Gastroenterology, 84, 1621, 10.1016/0016-5085(83)90392-X Jensen, 1984, Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome, Dig Dis Sci, 29, 363, 10.1007/BF01318525 McCarthy, 1984, The diagnosis and treatment of gastrinoma and Zollinger-Ellison syndrome, 347 Stabile, 1985, Benign and malignant gastrinoma, Am J Surg, 149, 144, 10.1016/S0002-9610(85)80024-6 Leroith, 1975, Somatostatin and serum gastrin in normal subjects and in patients with pernicious anemia, chronic liver and renal diseases, S Afr Med J, 49, 1601 Seal, 1982, Somatostatin-14 and -28: Clearance and potency on gastric function in dogs, Am J Physiol, 243, G97 Konturek, 1985, Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man, Scand J Gastroenterol, 20, 31, 10.3109/00365528509089629 Loud, 1985, Is somatostatin a humoral regulator of the endogenous pancreas and gastric acid secretion in man?, Gut, 26, 445, 10.1136/gut.26.5.445 Sheppard, 1979, Metabolic clearance and plasma half disappearance time of exogenous somatostatin in man, J Clin Endocrinol Metab, 48, 50, 10.1210/jcem-48-1-50 Ellison, 1986, Suppression of gastrin and gastric acid secretion in the Zollinger-Ellison syndrome by long-acting somatostatin (SMS 201-995), Scand J Gastroenterol, 21, 206, 10.3109/00365528609087454 Wood, 1985, Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue, 26, 438 Kraenzlin, 1985, Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases, Gastroenterology, 88, 185, 10.1016/S0016-5085(85)80153-0 Clements, 1985, Regression of metastatic VIPoma with somatostatin analogue SMS 201-995, Lancet, I, 874, 10.1016/S0140-6736(85)92235-4 Fajans, 1984, Diagnosis and treatment of “insulinoma”, 235 Hofeldt, 1974, Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma, Diabetes, 23, 192, 10.2337/diab.23.3.192 Brodows, 1974, Control of refractory fasting hypoglycemia in a patient with suspected insulinoma with diphenylhydantoin, J Clin Endocrinol Metab, 38, 159, 10.1210/jcem-38-1-159 Fajans, 1966, Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man, J Clin Invest, 45, 481, 10.1172/JCI105362 Fajans, 1968, Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man, Ann NY Acad Sci, 150, 261, 10.1111/j.1749-6632.1968.tb19051.x Neri, 1969, Effect of propranolol on the blood sugar, immunoreactive blood insulin in a patient with insulinoma, Acta Diabetol Lat, 6, 809, 10.1007/BF01548087 Blum, 1975, Prevention of hypoglycemic attacks by propranolol in a patient suffering from insulinoma, Diabetes, 24, 535, 10.2337/diab.24.6.535 Shaklai, 1977, Suppression of hypoglycemia attacks and insulin release by propranolol in a patient with metastatic malignant insulinoma, Diabete Metab, 3, 155 Schein, 1972, Chemotherapeutic management of the hormonesecreting endocrine malignancies, Cancer, 30, 1616, 10.1002/1097-0142(197212)30:6<1616::AID-CNCR2820300630>3.0.CO;2-O Broder, 1974, Chemotherapy of malignant insulinomas with streptozotocin, 714 Moertel, 1980, Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet-cell carcinoma, N Engl J Med, 303, 1189, 10.1056/NEJM198011203032101 Eastman, 1977, Adriamycin therapy for advanced insulinoma, J Clin Endocrinol Metab, 44, 142, 10.1210/jcem-44-1-142 Grahame-Smith, 1968, The carcinoid syndrome, Am J Cardiol, 21, 376, 10.1016/0002-9149(68)90142-2 Godwin, 1975, Carcinoid tumors: an analysis of 2837 cases, Cancer, 36, 560, 10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4 Gifford, 1964, Clinical features, diagnosis and treatment of pheochromocytoma: a review of 76 cases, Mayo Clin Proc, 39, 281 Cunliffe, 1968, A calcitonin-secreting thyroid carcinoma, Lancet, II, 63, 10.1016/S0140-6736(68)90352-8 Robertson, 1963, The mechanism of facial flushing in the carcinoid syndrome, Q J Med, 31, 103 Karim, 1971, Cardiovascular and other effects of prostaglandin E2 and F2 in man, Cardiovasc Res, 5, 255, 10.1093/cvr/5.3.255 Roberts, 1978, Prostaglandins: role in the humoral manifestations of medullary carcinoma of thyroid and inhibition by somatostatin, Trans Assoc Am Physicians, 92, 286 Said, 1980, Vasoactive intestinal polypeptide: isolation, distribution, biological actions, structure-function relationship, and possible functions, 245 Eklund, 1977, Effects of substance P on resistance and capacitance vessels in the human forearm, 275 Vinik, 1983, Unusual gastroenteropancreatic (GEP) tumors and their hormones, 293 Wilkin, 1981, Flushing reaction: consequences and mechanisms, Ann Intern Med, 95, 468, 10.7326/0003-4819-95-4-468 Frolich, 1978, The carcinoid flush: provocation by pentagastrin and inhibition by somatostatin, N Engl J Med, 299, 1055, 10.1056/NEJM197811092991908 Long, 1981, Somatostatin, gastrointestinal peptides, and carcinoid syndrome, Gut, 22, 549, 10.1136/gut.22.7.549 Barkin, 1983, Diabetes and the gastrointestinal system, 863 Fedorak, 1985, Treatment of diabetic diarrhea with clonidine, Ann Intern Med, 102, 197, 10.7326/0003-4819-102-2-197 Vinik, 1982, Hormonal secretion in diabetic autonomic neuropathy, N Y State J Med, 82, 871 Kothary, 1983, Immunochemical studies of molecular heterogeneity of cholecystokinin in duodenal perfusates and plasma in humans, J Biol Chem, 258, 2856, 10.1016/S0021-9258(18)32796-0 Santangelo, 1985, Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport, Ann Intern Med, 103, 363, 10.7326/0003-4819-103-3-363 Thompson, 1984, MEN I pancreas: a histological and immunohistochemical study, World J Surg, 8, 561, 10.1007/BF01654938 Thompson, 1985, Extrapancreatic gastrinomas, Surgery, 98, 1113 Pittenger, 1985, Regulation and actions of gastrointestinal somatostatin, 447 Whitehouse, 1984, SMS 201-995 (a long-acting, octapeptide somatostatin-analogue)-Efficacy and duration of action after s.c. administration on pentagastrin-stimulated gastric acid secretion in man (abstr), Dig Dis Sci, 29, 96S Ellison, 1986, Characterization of somatostatin inhibition of gastrin secretion from gastrinoma in vivo and in vitro Walsh, 1975, Gastrin, N Engl J Med, 292, 1324, 10.1056/NEJM197506192922505 Walsh, 1975, Gastrin, N Engl J Med, 292, 1377, 10.1056/NEJM197506262922605 Stadil, 1976, Treatment of Zollinger-Ellison syndrome with streptozotocin, N Engl J Med, 294, 1440, 10.1056/NEJM197606242942608 Haller, 1985, Chemotherapeutic management of endocrine-producing tumors of the gastrointestinal tract, 129 Thompson, 1975, Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome, Surg Gynecol Obstet, 140, 721 Zollinger, 1976, Observations on the postoperative tumor growth behavior of certain islet cell tumors, Ann Surg, 184, 525, 10.1097/00000658-197610000-00016 Passaro, 1974, Malignant gastrinoma following total gastrectomy, Arch Surg, 108, 444, 10.1001/archsurg.1974.01350280050009 Schally, 1985, Antitumor effects of analogs of hypothalmic hormones in endocrine-dependent cancers, 175, 259 Reichlin, 1983, Somatostatin, N Engl J Med, 309, 1495, 10.1056/NEJM198312153092406 Reichlin, 1983, Somatostatin, N Engl J Med, 309, 1556, 10.1056/NEJM198312223092506 Tannenbaum, 1982, Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release, Endocrinology, 111, 101, 10.1210/endo-111-1-101 Mandarino, 1981, Selective effects of somatostatin-14, -25, -28 on in vitro insulin and glucagon secretion, Nature, 291, 76, 10.1038/291076a0 Dollinger, 1976, Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man, Horm Metab Res, 8, 74, 10.1055/s-0028-1093677 Scuro, 1976, Somatostatin inhibition of insulin secretion in insulin-producing tumors, Metabolism, 25, 603, 10.1016/0026-0495(76)90056-1 Hirsch, 1977, Hypoglycemia of infancy and nesidioblastosis studies with somatostatin, N Engl J Med, 296, 1323, 10.1056/NEJM197706092962305 Verschoor, 1985, Prevention of hypoglycemia in patients with insulinoma (abstr), Diabetes, 34, 13A Osei, 1985, Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones, Ann Intern Med, 103, 223, 10.7326/0003-4819-103-2-223 Lewis, 1986, The role of long-acting somatostatin analogue (SMS 201-995) in the management of a patient with a benign insulin-secreting adenoma of the pancreas and a postoperative pancreatic fistula, Scand J Gastroenterol, 21, 217, 10.3109/00365528609087456 Kahn, 1981, Use of somatostatin and somatostatin analogs in a patient with a glucagonoma, J Clin Endocrinol Metab, 53, 543, 10.1210/jcem-53-3-543 Adamson, 1969, Pharmacological blockade of carcinoid flushing provoked by catecholamines and alcohol, Lancet, II, 293, 10.1016/S0140-6736(69)90056-7 Gottesman, 1982, Somatostatin: its role in health and disease, Volume 4, 177 Sjoerdsma, 1960, Serotonin synthesis in carcinoid patients: its inhibition by alpha-methyl-DOPA, with measurement of associated increases in urinary 5-hydroxytryptophas, N Engl J Med, 263, 585, 10.1056/NEJM196009222631204 Strodel, 1983, Carcinoid tumors of the small intestine, 293 Mason, 1966, Abnormal forearm vascular responses in the carcinoid syndrome: the role of kinins and kinin generating system, J Clin Invest, 45, 1685, 10.1172/JCI105475 Engleman, 1967, Inhibition of serotonin synthesis by parachlorophenylalamine in patients with the carcinoid syndrome, N Engl J Med, 277, 1103, 10.1056/NEJM196711232772101 Powell, 1976, Participation of H1 and H2 histamine receptors in physiological vasodilator responses, Am J Physiol, 231, 1002, 10.1152/ajplegacy.1976.231.4.1002 Dharmsathaphorn, 1985, Intestinal somatostatin function, 463 Davis, 1980, Effects of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome, Gastroenterology, 78, 346, 10.1016/0016-5085(80)90586-7 Mulvihill, 1984, Severe diarrhea after colonic pseudo-obstruction: treatment with somatostatin, N Engl J Med, 310, 467, 10.1056/NEJM198402163100719 Williams, 1984, Use of a long-acting somatostatin analogue in controlling life-threatening ileostomy diarrhoea, Br Med J, 289, 1027, 10.1136/bmj.289.6451.1027 Ruskone, 1982, Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera, Dig Dis Sci, 27, 459, 10.1007/BF01295657 Maton, 1985, Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera, N Engl J Med, 312, 17, 10.1056/NEJM198501033120104 Tsai, 1986, Diabetic diarrhea and somatostatin, Ann Intern Med, 104, 894, 10.7326/0003-4819-104-6-894_1 Dharmsathaphorn, 1982, Somatostatin decreases diarrhea in patients with the short bowel syndrome, J Clin Gastroenterol, 4, 521, 10.1097/00004836-198212000-00008 Jaros, 1985, Successful treatment of idiopathic secretory diarrhea of infancy with a somatostatin analogue SMS 201-995, Gastroenterology, 88, 1432 Rosenthal, 1983, Structure-activity relationship of somatostatin analogs in the rabbit ileum and the rat colon, J Clin Invest, 71, 840, 10.1172/JCI110838 Santangelo, 1985, Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport, Ann Intern Med, 103, 363, 10.7326/0003-4819-103-3-363 Spinas, 1985, Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin analogue (SMS 201-995) in insulin-dependent diabetes mellitus, Diabetes Care, 8, 429, 10.2337/diacare.8.5.429